University Briefs

Cambridge Welcomes Entrepreneurs Cambridge University has traditionally lagged far behind its U.S counterparts in spawning a ring of high-tech industries (The Scientist, May 16, page 8), but now an “innovation center” founded by Trinity College in 1986 has been so successful that the college will open another this month. Meanwhile, St. John’s College has opened an incubator of its own on a 22-acre site owned by the college. To date, St. John’s has invested $9 million in

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Cambridge University has traditionally lagged far behind its U.S counterparts in spawning a ring of high-tech industries (

Pity biochemist Kauko K. Makinen of the University of Michigan in Ann Arbor: The very success of his research has slowed the pace of scientific progress. Since 1969, Makinen has been examining the effect of xylitol, a sugar alcohol, on tooth decay in children. While a professor at the University of Turku dental school in Finland, Makinen conducted a five-year study of 324 children and found that those who regularly chewed gum containing xylitol had 53% fewer cavities than those who didn’t. Now, Makinen wants to pinpoint the lowest effective xylitol dosage, and determine whether chewing gum is the ideal delivery system. But his earlier findings have become so widely known in Finland that he can’t find a control group there. “Everyone chews this gum,” Makinen laments. “Dentists recommend xylitol to children ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies